BridgeBio Pharma, Inc. (BBIO) compared with its closest peers (TVTX, MIRM, NATR, ORGO, CPRX). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Travere Therapeutics, Mirum Pharmaceuticals, Nature's Sunshine Products, Organogenesis, Catalyst Pharmaceuticals, Insmed, OPKO Health, Innoviva, Ardelyx and Esperion Therapeutics share BridgeBio Pharma's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | $6.07B | -131.8 |
| Mirum Pharmaceuticals, Inc. (MIRM) | $5.90B | -168.0 |
| Nature's Sunshine Products, Inc. (NATR) | $251.88M | 13.2 |
| Organogenesis Holdings Inc. (ORGO) | $213.60M | 34.5 |
| Catalyst Pharmaceuticals, Inc. (CPRX) | $3.85B | 17.1 |
| Insmed Incorporated (INSM) | $27.05B | -27.1 |
| OPKO Health, Inc. (OPK) | $1.11B | -4.2 |
| Innoviva, Inc. (INVA) | $1.52B | 4.0 |
| Ardelyx, Inc. (ARDX) | $930.72M | -22.4 |
| Esperion Therapeutics, Inc. (ESPR) | $821.21M | -33.7 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.1 |
BBIO overview · BBIO earnings · BBIO financials · BBIO KPIs · BBIO documents · BBIO ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.